12-56781985-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000322165.1(HSD17B6):āc.325C>Gā(p.Leu109Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000322165.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSD17B6 | NM_003725.4 | c.325C>G | p.Leu109Val | missense_variant | 3/5 | ENST00000322165.1 | NP_003716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSD17B6 | ENST00000322165.1 | c.325C>G | p.Leu109Val | missense_variant | 3/5 | 1 | NM_003725.4 | ENSP00000318631 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 250996Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135600
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461666Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727084
GnomAD4 genome AF: 0.000151 AC: 23AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2021 | The c.325C>G (p.L109V) alteration is located in exon 3 (coding exon 2) of the HSD17B6 gene. This alteration results from a C to G substitution at nucleotide position 325, causing the leucine (L) at amino acid position 109 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at